pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
vorasidenib citrate
Voranigo (vorasidenib citrate)
Low-Grade Glioma
Les Laboratoires Servier SAS
0 catalysts
Phase 2
voretigene neparvovec
Luxturna (voretigene neparvovec-rzyl)
Choroideremia
Retinoid isomerohydrolase
F. Hoffmann-La Roche Ltd
0 catalysts
Marketed
vorinostat
Zolinza (vorinostat)
Cutaneous T-Cell Lymphoma
$MRKMerck & Co., Inc.
catalysts
← prev
page 269 of 271
next →
131
Pain89
Neurology1
0
Phase 3
vorolanib
DURAVYU (vorolanib [INN])
Wet (Neovascular / Exudative) Macular Degeneration
$EYPTEyePoint, Inc.
0 catalysts
Marketed
vortioxetine hydrobromide
Trintellix (vortioxetine hydrobromide)
Major Depressive Disorder
Takeda Pharmaceuticals USA Inc
0 catalysts
Phase 2
vosilasarm
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Ellipses Pharma Ltd
0 catalysts
Marketed
vosoritide
Voxzogo (vosoritide)
Noonan Syndrome
Atrial natriuretic peptide receptor 2
$BMRNBIOMARIN PHARMACEUTICAL INC
0 catalysts
Phase 3
votoplam
Huntington Disease
$NVSNOVARTIS AG
0 catalysts
Phase 2
vusolimogene oderparepvec
Basal Cell Carcinoma (Basal Cell Epithelioma)
$REPLReplimune Group, Inc.
0 catalysts
Marketed
vutrisiran
Amvuttra (vutrisiran)
Familial Amyloid Cardiomyopathy
$ALNYALNYLAM PHARMACEUTICALS, INC.
0 catalysts
Marketed
warfarin sodium
Jantoven (warfarin sodium)
Myocardial Infarction
Upsher-Smith Laboratories LLC
0 catalysts
Marketed
wasp venom [Polistes] allergen extract
Wasp Venom Protein Multidose
Allergies
Jubilant HollisterStier LLC
0 catalysts
Marketed
western diamondback rattlesnake [Crotalus atrox] + eastern diamondback rattlesnake [Crotalus adamanteus] + mojave rattlesnake [Crotalus scutulatus] + cottonmouth/water moccasin [Agkistrodon piscivorus] (polyvalent) immunoglobulin Fab antivenom [ovine]
CroFab
Poisoning
BTG International Inc
0 catalysts
Phase 3
xaluritamig
xaluritamig [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$AMGNAMGEN INC
0 catalysts
Phase 2
xelafaslatide
Retinal Pigment Epithelial (RPE) Detachment
ONL Therapeutics Inc
0 catalysts
Phase 1
xirestomig
xirestomig [INN]
Non-Hodgkin Lymphoma
Antengene Corp Ltd
0 catalysts
Marketed
yellow fever [strain 17 D-204] vaccine
YF-Vax
Yellow Fever
Sanofi Pasteur Inc
0 catalysts
Phase 2
zabilugene almadenorepvec
Pancreatic Ductal Adenocarcinoma
$TOVXTheriva Biologics, Inc.
0 catalysts
Marketed
zafirlukast
Zafirlukast (zafirlukast)
Chronic Asthma
Camber Pharmaceuticals Inc
0 catalysts
Phase 2
zagociguat
MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-L…
Tisento Therapeutics Inc
0 catalysts
Marketed
zaleplon
Zaleplon (zaleplon)
Insomnia
Orchid Pharma Inc
0 catalysts
Phase 2
zalifrelimab
Cervical Cancer
Cytotoxic T-lymphocyte protein 4
$AGENAGENUS INC
0 catalysts
Phase 1
zaloblideg
zaloblideg [INN]
Diffuse Large B-Cell Lymphoma
$ARVNARVINAS, INC.
0 catalysts
Phase 3
zaloganan
zaloganan [INN]
Prosthetic Joint infections
Peptilogics Inc
0 catalysts
Phase 1
zalsupindole
zalsupindole [INN]
Major Depressive Disorder
Delix Therapeutics Inc
0 catalysts
Phase 2
zaltenibart
Paroxysmal Nocturnal Hemoglobinuria
Novo Nordisk AS
0 catalysts
Phase 3
zalunfiban acetate
Myocardial Infarction
CeleCor Therapeutics Inc
0 catalysts
Phase 2
zampilimab
zampilimab [INN]
Idiopathic Pulmonary Fibrosis
Chiesi Farmaceutici SpA
0 catalysts
Preclinical
zanamivir
Relenza (zanamivir)
Influenzavirus A Infections
Therapeutic Systems Research Laboratories Inc
0 catalysts
pre_registration
zanidatamab
Ziihera (zanidatamab-hrii)
Adenocarcinoma Of The Gastroesophageal Junction
Receptor tyrosine-protein kinase erbB-2
$JAZZJazz Pharmaceuticals plc
0 catalysts